LifePlus Establishes Global Clinical Validation for First-of-Its-Kind Non-Invasive Glucose and Cuffless BP Monitoring Device and Platform

LifePlus clinically validates first non-invasive wearable for glucose and blood pressure monitoring

Product eliminates the need for needles, cuffs, and calibration.

LifePlus Establishes Global Clinical Validation for First-of-Its-Kind Non-Invasive Glucose and Cuffless BP Monitoring Device and Platform

SAN JOSE, Calif.--(BUSINESS WIRE)--Jun 23, 2025-

LifePlus clinically validates first non-invasive wearable for glucose and blood pressure monitoring – RamaOnHealthcare

Key TakeawaysLifeLeaf is a non-invasive, cuffless wearable device for continuous blood glucose and blood pressure monitoring, validated in multi-center

LifePlus reports clinical validation of non-invasive glucose monitor

The LifeLeaf non-invasive glucose and blood sugar monitor. [Image from LifePlus]LifePlus today announced the clinical validation of its LifeLeaf non-invasive and cuffless wearable for continuous glucose and blood pressure tracking. The device delivers real-time insights without needles, invasive sensors or cuffs. Global, multi-center trials conducted across the Mayo Clinic, AMCR Clinic – San Diego Cleveland Clinic – Abu Dhabi, and Hospital Sebar…